Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 14 January 2003
Vol. 2003, Issue 165, p. tw29
[DOI: 10.1126/stke.2003.165.tw29]


Antidepressants Therapeutically Altering Adrenergic Receptor Recycling

Reduced adrenergic receptors either postsynaptically in vivo or on the cell surface of cultured cells is one result of chronic treatment with antidepressants. Bürgi et al. determined that chronic treatment of cultured rat C6 glioblastoma cells with desipramine, a tricyclic antidepressant, inhibits the reappearance of green fluorescent protein (GFP)-tagged β1-adrenergic receptors (GFP-β1AR). Several preliminary studies were performed to show that the GFP tag did not interfere with ligand binding, with G protein coupling, or with receptor internalization or recycling in cells not exposed to desipramine. The GFP-β1AR did not accumulate in lysosomes after desipramine exposure; instead, the protein accumulated in a recycling compartment that colocalized with internalized transferrin receptors. Transferrin receptor recycling to the plasma membrane was not impaired by desipramine treatment. Thus, tricyclic antidepressants may decrease β1AR surface expression by altering receptor trafficking, instead of by prolonging agonist stimulation.

S. Bürgi, K. Baltensperger, Y. E. Honegger, Antidepressant-induced switch of β1-adrenoceptor trafficking as a mechanism for drug action. J. Biol. Chem. 278, 1044-1052 (2003). [Abstract] [Full Text]

Citation: Therapeutically Altering Adrenergic Receptor Recycling. Sci. STKE 2003, tw29 (2003).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882